RY 151.2 -0.6636% TD 80.12 0.9577% SHOP 83.0 1.3802% CNR 158.42 -0.9751% ENB 50.51 0.0198% CP 113.01 0.9108% BMO 119.55 0.3357% TRI 227.18 0.6334% CNQ 47.185 -0.851% BN 64.45 1.7524% ATD 82.17 -0.8208% CSU 4335.0 0.7153% BNS 62.975 -0.3402% CM 69.78 0.7508% SU 53.02 0.9136% TRP 57.81 1.1018% NGT 63.51 -3.5535% WCN 241.16 -2.9029% MFC 35.73 0.7614% BCE 45.805 0.0546%

Lifeist Wellness Inc

Healthcare CA LFST

0.135CAD
-0.025(15.62%)

Last update at 2024-07-25T15:01:00Z

Day Range

0.130.15
LowHigh

52 Week Range

0.0050.08
LowHigh

Fundamentals

  • Previous Close 0.16
  • Market Cap5.48M
  • Volume55696
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-11.93376M
  • Revenue TTM23.17M
  • Revenue Per Share TTM0.05
  • Gross Profit TTM 1.68M
  • Diluted EPS TTM-0.04

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-11-30 2021-11-30 2020-11-30 2019-11-30 2018-11-30
Type yearly yearly yearly yearly yearly
Date 2022-11-30 2021-11-30 2020-11-30 2019-11-30 2018-11-30
Income before tax -18.92025M -23.63596M -26.18012M -63.59583M -23.62162M
Minority interest - 0.00000M 0.18M 0.06M 0.01M
Net income -15.43550M -23.80075M -26.24923M -63.16702M -23.22206M
Selling general administrative 17.31M 24.33M 23.78M 24.49M 27.22M
Selling and marketing expenses - - - - -
Gross profit 3.79M 1.68M 1.46M 1.36M 5.18M
Reconciled depreciation 1.47M 2.04M 2.19M 2.50M 1.64M
Ebit - -25.32757M -26.19883M -27.11917M -33.37052M
Ebitda -17.44379M -21.49713M -24.01240M -25.12629M -20.40587M
Depreciation and amortization - - - - -
Non operating income net other - - - - -
Operating income -15.12140M -25.32757M -26.19883M -27.62795M -22.04579M
Other operating expenses - - - - 1.70M
Interest expense 0.00246M 0.10M 0.00000M 0.00000M 0.00000M
Tax provision -0.22425M 0.16M 0.25M -0.36547M -0.38848M
Interest income - - 0.25M 1.23M 0.30M
Net interest income -0.00246M -0.09502M 0.25M 1.23M 0.30M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - 0.16M 0.25M -0.36547M -0.33765M
Total revenue 22.07M 22.82M 25.10M 16.34M 18.56M
Total operating expenses 37.19M 48.15M 51.30M 43.97M 40.61M
Cost of revenue 18.27M 21.14M 23.65M 14.98M 13.38M
Total other income expense net -3.79640M 1.79M -0.23319M -37.19543M -1.87740M
Discontinued operations - - - - -
Net income from continuing ops -18.69599M -23.80075M -26.42946M -63.23035M -23.23314M
Net income applicable to common shares - -23.80075M -26.24923M -63.16702M -33.27697M
Preferred stock and other adjustments - - - - -
Breakdown 2022-11-30 2021-11-30 2020-11-30 2019-11-30 2018-11-30
Type yearly yearly yearly yearly yearly
Date 2022-11-30 2021-11-30 2020-11-30 2019-11-30 2018-11-30
Total assets 20.67M 37.96M 39.23M 67.72M 71.08M
Intangible assets 1.42M 5.17M 6.10M 7.56M 17.54M
Earning assets - - - - -
Other current assets - - 0.00669M 0.18M 0.08M
Total liab 7.30M 11.89M 10.24M 11.94M 5.38M
Total stockholder equity 13.36M 26.06M 29.25M 55.86M 65.71M
Deferred long term liab - - - - -
Other current liab 0.54M 2.55M 1.33M 4.56M 0.12M
Common stock - 153.89M 133.99M 133.99M 124.78M
Capital stock 156.35M 153.89M 133.99M 133.99M 86.03M
Retained earnings -192.06653M -176.63103M -152.83029M -126.58105M -63.08539M
Other liab - 0.31M 0.05M 0.28M 0.72M
Good will 0.67M 0.67M 0.67M 0.67M 7.75M
Other assets - 0.44M 0.44M 2.36M 0.10M
Cash 3.80M 12.74M 10.28M 37.86M 34.40M
Cash and equivalents - - - - -
Total current liabilities 7.12M 11.22M 9.65M 11.66M 6.66M
Current deferred revenue - - - - -
Net debt - - - - -
Short term debt - - - - -
Short long term debt - - - 0.02M 0.02M
Short long term debt total - - - - -
Other stockholder equity - 29.54M 29.01M 44.35M 47.59M
Property plant equipment - 3.72M 4.97M 1.34M 1.22M
Total current assets 15.06M 27.60M 26.17M 51.08M 87.50M
Long term investments 0.08M 0.36M 0.88M 4.71M 2.60M
Net tangible assets - 20.23M 22.49M 47.63M 85.13M
Short term investments - - - - -
Net receivables 3.34M 6.41M 5.88M 2.50M 1.80M
Long term debt - - - - 0.03M
Inventory 4.54M 5.37M 8.13M 6.00M 5.77M
Accounts payable 2.22M 1.90M 1.87M 2.44M 2.83M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - -0.00000M 1.89M -
Deferred long term asset charges - - - - -
Non current assets total 5.61M 10.36M 13.06M 16.64M 29.04M
Capital lease obligations 0.33M 0.55M 0.76M - -
Long term debt total - - - - -
Breakdown 2022-11-30 2021-11-30 2020-11-30 2019-11-30 2018-11-30
Type yearly yearly yearly yearly yearly
Date 2022-11-30 2021-11-30 2020-11-30 2019-11-30 2018-11-30
Investments 6.69M 0.00528M 0.78M -1.85531M -1.85531M
Change to liabilities - 0.00000M 0.15M 1.06M 0.00000M
Total cashflows from investing activities - -0.22958M -2.69591M -6.16943M -6.16943M
Net borrowings - -0.28061M -0.28547M -0.02084M -0.02084M
Total cash from financing activities -0.25229M 21.02M -0.28424M 3.78M 3.78M
Change to operating activities - -1.52669M 1.79M -0.92057M -0.92057M
Net income -15.43550M -23.80075M -26.24923M -63.16702M -33.27697M
Change in cash -8.90976M 2.46M -27.57802M -40.35466M -40.35466M
Begin period cash flow 12.74M 10.28M 37.86M 78.21M 1.13M
End period cash flow 3.80M 12.74M 10.28M 37.86M 34.40M
Total cash from operating activities -15.34681M -18.27699M -24.53815M -37.88881M -37.88881M
Issuance of capital stock 0.07M 18.96M - 0.00000M 43.88M
Depreciation 1.47M 1.52M 1.43M 1.73M 1.73M
Other cashflows from investing activities - - -0.04032M -1.81258M -1.81258M
Dividends paid - - - - -
Change to inventory 0.83M 2.76M -1.19710M -1.59576M -1.59576M
Change to account receivables - 1.15M -4.73140M -0.69246M -0.69246M
Sale purchase of stock - - 0.00000M -0.51140M -2.99187M
Other cashflows from financing activities - 2.34M 2.34M 2.34M 2.34M
Change to netincome - 0.23M 3.50M 24.93M 24.93M
Capital expenditures 0.69M 0.37M 3.44M 0.53M 0.53M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -0.15695M 3.25M -4.74772M -2.15179M -1.27617M
Stock based compensation 0.76M 1.26M 0.77M 2.02M -
Other non cash items 0.90M -1.61957M -0.00838M -0.04380M 0.28M
Free cash flow -16.04021M -18.64328M -27.97592M -40.39035M -14.33663M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change (CAD) Price (CAD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
LFST
Lifeist Wellness Inc
-0.025 15.62% 0.14 - - 0.24 0.58 0.21 -0.3287
RX
Biosyent Inc.
-0.19 1.88% 9.91 16.47 16.26 3.21 2.88 2.32 8.03
LOVE
Cannara Biotech Inc
-0.04 6.67% 0.56 10.00 - 1.26 0.90 1.98 7.20
DB
Decibel Cannabis Company Inc
- -% 0.06 - 3.38 0.48 1.17 0.87 39.48
LSL
LSL Pharma Group Inc.
-0.005 1.04% 0.47 - - 4.65 4.23 6.13 -14.2493

Reports Covered

Stock Research & News

Profile

Lifeist Wellness Inc. operates as a wellness company in the United States and Canada. The company operates an online marketplace for hemp-derived CBD and accessories; and a butane hash oil extraction facility. It also distributes licensed and in-house branded adult-use cannabis and cannabis derived products; and supplies hardware, including vaporizers and related accessories, as well as engages in the biosciences and consumer wellness business. The company was formerly known as Namaste Technologies Inc. and changed its name to Lifeist Wellness Inc. in September 2021. Lifeist Wellness Inc. is based in Vancouver, Canada.

Lifeist Wellness Inc

666 Burrard Street, Vancouver, BC, Canada, V6C 2X8

Key Executives

Name Title Year Born
Mr. Meni Morim CEO & Director NA
Ms. Slava Klems C.A., CPA Chief Financial Officer NA
Mr. Faraaz Jamal Chief Operating Officer NA
Mr. Chad Agate Chief Technology Officer NA
Mr. Alexander Liszka Gen. Counsel NA
Mr. David Hughes Chief Marketing Officer NA
Mr. Lars Pastrik VP of People & Culture NA
Ms. Chelsea Palmer Exec. Assistant NA
Mr. Tim Henley Advisory Consultant NA
Mr. Paul Neider Advisory Consultant NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.